Clinical study overview*

Study Name Study Type Patients Status Primary Endpoint
BIOSTEMI RCT 1300 24-month FU available TLF at 24 months
Taglieri et al. Network Meta-Analysis 99039 - TLF at 12 months and the longest FU available
BIOFLOW-V RCT 1334 60-months FU available TLF at 12 months
BIO-RESORT RCT 3514 Completed, 60-month FU available TVF at 12 months
BIONYX RCT 2488 36-month FU available TVF at 12 months
BIOSCIENCE RCT 2119 Completed, 60-month FU available TLF at 12 months
Madhavan et al. Meta-Analysis 20701 - TLF at mean 30 months
TICO RCT 3056 Completed, primary endpoint reached NACE at 12 months
SMART-CHOICE RCT 3000 Primary endpoint reached MACCE at 15 months
SCAAR All comers registry 69570 24-month FU available -
SORT OUT X RCT 3146 12-month FU available TLF at 12 months
SORT OUT IX RCT 3151 24-month FU available TLF at 12 months
BIODEGRADE RCT 3850 36-month FU available TLF at 18 months
BIOFLOW-III Single arm registry 1356 Completed, 60-month FU available TLF at 12 months
BIOFLOW-IV RCT 575 Completed, 60-month FU available TVF at 12 months
BIOFLOW-VI RCT 440 60-months FU available LLL at 9 months
HEROES Single arm registry 353 36-month FU available DOCE at 12 months
ROSES Single arm registry 460 Preliminary results available TLF at 12 months
ORIENT RCT 372 36-month FU available LLL at 9 months
Hattrick-OCT
RCT 44 Primary endpoint reached Strut coverage at 3 months
ISAR OCT RCT 39 Primary endpoint reached Strut coverage at 6 months
PRISON-IV RCT 330 36-month FU available LLL at 9 months
PREPARE-CALC RCT 200 Completed Strategy success and LLL at 9 months
BIOFLOW-I
FIM 30 Completed, 12-month FU available LLL at 9 months
BIOFLOW-II RCT 452 Completed, 60-month FU available LLL at 9 months
BIOLUX-RCT RCT 210 18-month FU available LLL at 6 months
REVELATION RCT 120 Primary endpoint reached FFR at 9 months

*a selection of the full clinical program of the Orsiro family.

Are you interested in specific study data?

CONTACT US